| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 279,7 k € | +20.6% | 231,9 k € | +17.6% | 197,3 k € | -4.0% | 205,4 k € | +10.7% | 185,6 k € | +3.4% | 179,4 k € | +5.8% | 169,5 k € | +29.9% | 130,5 k € | -19.0% | 161,1 k € | +16.2% | 138,6 k € | +63.3% | 84,9 k € | +51.7% | 56,0 k € | +0.5% | 55,7 k € | -14.2% | 64,9 k € | +663.7% | 8,5 k € | +103.5% | 4,2 k € | |
| EBITDA | 232,4 k € | +21.5% | 191,2 k € | +20.4% | 158,8 k € | -6.7% | 170,2 k € | +10.1% | 154,6 k € | +6.6% | 145,0 k € | +6.8% | 135,7 k € | +33.5% | 101,6 k € | -24.7% | 134,9 k € | +18.8% | 113,5 k € | +70.6% | 66,5 k € | +21.4% | 54,8 k € | +1.0% | 54,2 k € | -14.6% | 63,5 k € | +974.3% | 5,9 k € | +84.0% | 3,2 k € | |
| Operating profit | 183,2 k € | +12.2% | 163,3 k € | +27.6% | 128,0 k € | -8.4% | 139,7 k € | +8.1% | 129,2 k € | +9.4% | 118,1 k € | +6.6% | 110,8 k € | +18.4% | 93,6 k € | -25.9% | 126,2 k € | +20.4% | 104,8 k € | +64.2% | 63,8 k € | +28.3% | 49,7 k € | +0.7% | 49,4 k € | -13.5% | 57,2 k € | +5047.6% | 1,1 k € | +387.2% | -386,6 € | |
| Profit/loss | 133,1 k € | +11.5% | 119,4 k € | +25.1% | 95,5 k € | -5.5% | 101,0 k € | +1.4% | 99,6 k € | +16.9% | 85,2 k € | +4.4% | 81,6 k € | +36.7% | 59,7 k € | -30.6% | 86,0 k € | +15.6% | 74,4 k € | +51.7% | 49,0 k € | +33.3% | 36,8 k € | -2.2% | 37,6 k € | -7.2% | 40,5 k € | +10573.3% | 379,6 € | +151.8% | -733,3 € | |
| Equity | 774,7 k € | +20.7% | 641,6 k € | +10.3% | 581,9 k € | +19.6% | 486,4 k € | +26.2% | 385,4 k € | +34.8% | 285,8 k € | +42.5% | 200,7 k € | +68.6% | 119,0 k € | +100.6% | 59,3 k € | +11.2% | 53,4 k € | -54.0% | 116,0 k € | +73.2% | 66,9 k € | -25.7% | 90,2 k € | +71.6% | 52,6 k € | +336.3% | 12,0 k € | +120.4% | 5,5 k € | |
| Total assets | 1,1 M € | +8.5% | 979,2 k € | +24.7% | 785,2 k € | +8.3% | 725,1 k € | +9.9% | 659,8 k € | +40.2% | 470,5 k € | +31.8% | 357,0 k € | +110.1% | 169,9 k € | -13.9% | 197,3 k € | -18.5% | 242,0 k € | +83.6% | 131,8 k € | -7.8% | 143,0 k € | +33.9% | 106,8 k € | +33.3% | 80,1 k € | +155.7% | 31,3 k € | -34.3% | 47,7 k € | |
| Cash | 14,1 k € | +17.7% | 12,0 k € | -29.5% | 17,1 k € | -33.2% | 25,5 k € | +11.9% | 22,8 k € | -27.9% | 31,6 k € | +384.1% | 6,5 k € | +41.2% | 4,6 k € | -90.8% | 50,2 k € | -36.4% | 78,8 k € | +88.6% | 41,8 k € | +259.9% | 11,6 k € | +66.2% | 7,0 k € | +647.9% | 934,6 € | +35435.0% | 2,6 € | -99.7% | 828,1 € | |
| Debts | 281,0 k € | -15.1% | 331,1 k € | +66.0% | 199,4 k € | -15.1% | 235,0 k € | -13.2% | 270,7 k € | +51.6% | 178,6 k € | +17.9% | 151,5 k € | +228.3% | 46,2 k € | -65.7% | 134,5 k € | -27.4% | 185,4 k € | +1384.7% | 12,5 k € | -82.7% | 72,4 k € | +454.5% | 13,0 k € | -46.8% | 24,5 k € | +27.1% | 19,3 k € | -54.3% | 42,2 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 1 | 0,8 | — | — | — | — | — | ||||||||||||||||
Private limited company · Oudenaarde · incorporated on 24/04/2009
Private limited company profitable and well capitalised. Cash position rising (+17.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Geert Truijen, uroloog is a Private limited company incorporated in 2009. Its main activity is: Specialist medical practice activities. Its registered office is in Oudenaarde.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette